To determine the feasibility of delivering modified intensive chemotherapy to children with A-T who present with cancer. The completion of treatment [clinicaltrials_resource:a58df234baa41f4346107cb3260d8145]
Acute Lymphoblastic Leukemia (ALL) Low Risk
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
To determine the feasibility of delivering modified intensive chemotherapy to children with A-T who present with cancer. The completion of treatment [clinicaltrials_resource:a58df234baa41f4346107cb3260d8145]
Acute Lymphoblastic Leukemia (ALL) Low Risk
Bio2RDF identifier
a58df234baa41f4346107cb3260d8145
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a58df234baa41f4346107cb3260d8145
measure [clinicaltrials_vocabulary:measure]
To determine the feasibility o ...... h A-T who present with cancer.
time frame [clinicaltrials_vocabulary:time-frame]
The completion of treatment
description
Acute Lymphoblastic Leukemia (ALL) Low Risk
identifier
clinicaltrials_resource:a58df234baa41f4346107cb3260d8145
title
To determine the feasibility o ...... r. The completion of treatment
@en
type
label
To determine the feasibility o ...... df234baa41f4346107cb3260d8145]
@en